INTRAVITREAL PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED AMIKACIN IN A RABBIT MODEL

被引:0
|
作者
ZENG, S
HU, CZ
WEI, HR
LU, YS
ZHANG, Y
YANG, JX
YUN, GX
ZOU, WP
SONG, BP
机构
[1] TONGJI MED UNIV,TONGJI HOSP,FAC PHARM,WUHAN,PEOPLES R CHINA
[2] TONGJI MED UNIV,TONGJI HOSP,DEPT PHARM,WUHAN,PEOPLES R CHINA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background. Intravitreal injection of antibiotics has become a standard therapy for bacterial endophthalmitis. The duration of effective antimicrobial levels in the vitreous after single injection, however, may not be long enough to get optimal response. The authors prepared liposome-encapsulated amikacin for prolonging the duration of intravitreal therapeutic concentrations and investigated the intravitreal pharmacokinetics of the liposomes and amikacin in phosphate buffer solution (PBS) as control. Methods: The liposome-encapsulated amikacin was prepared by reverse-phase evaporation method. The intravitreal pharmacokinetics of the liposomes was compared with amikacin in PBS by fluorescence polarization immunoassay. Albino rabbits were randomly distributed into 12 groups. Rabbits in groups 1 to 6 and in groups I to VI (control groups) received an intravitreal injection of the liposome-encapsulated amikacin and amikacin in PBS, respectively. Results: The encapsulation rate of amikacin was 91%. The time of 50% spontaneous degradation (half-life) of the liposomes in PBS (38-degrees-C, pH 7.4) was 47.6 days, and the time of 50% release (half-life) of the drug from the liposomes in PBS was 84.8 hours. The vitreous amikacin concentrations in groups 1 to 6 were significantly greater (P < 0.05) than those in control groups I to VI in every time interval, except in groups 1 to 3 at 1 hour after injection. The difference was particularly obvious in the endophthalmitis groups. The clearance of encapsulated amikacin in vitreous appeared to be related to the state of blood-ocular barrier and to the structural integrity of vitreous. The distribution, the absorption, and the elimination of encapsulated amikacin in vitreous showed the first-order kinetics. Conclusion: The liposome-encapsulated amikacin prolonged half-life of the drug in vitreous. The results of the pharmacokinetic analysis suggested that in endophthalmitis, especially in severe cases, the liposomes may be preferable to conventional preparation.
引用
收藏
页码:1640 / 1644
页数:5
相关论文
共 50 条
  • [1] INTRAVITREAL LIPOSOME-ENCAPSULATED TRIFLUOROTHYMIDINE IN A RABBIT MODEL
    LIU, KR
    PEYMAN, GA
    KHOOBEHI, B
    ALKAN, H
    FISCELLA, R
    [J]. OPHTHALMOLOGY, 1987, 94 (09) : 1155 - 1159
  • [2] INTRAVITREAL INJECTION OF LIPOSOME-ENCAPSULATED GANCICLOVIR IN A RABBIT MODEL
    PEYMAN, GA
    KHOOBEHI, B
    TAWAKOL, M
    SCHULMAN, JA
    MORTADA, HA
    ALKAN, H
    FISCELLA, R
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1987, 7 (04): : 227 - 229
  • [3] INTRAVITREAL LIPOSOME-ENCAPSULATED GENTAMICIN IN A RABBIT MODEL - PROLONGED THERAPEUTIC LEVELS
    FISHMAN, PH
    PEYMAN, GA
    LESAR, T
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1986, 27 (07) : 1103 - 1106
  • [4] Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine
    GarciaArumi, J
    Pascual, R
    Fonseca, MJ
    Isart, FR
    Casaroli, R
    Mateo, C
    Corcostegui, B
    [J]. OPHTHALMOLOGICA, 1997, 211 (06) : 344 - 350
  • [5] PHARMACOKINETICS AND RETINAL TOXICITY OF INTRAVITREAL LIPOSOME-ENCAPSULATED 5-FLUOROURIDINE
    GARCIAARUMI, J
    SALVADOR, F
    CORCOSTEGUI, B
    FONSECA, MJ
    REIG, F
    MATEO, C
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1907 - 1907
  • [6] PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED DOXORUBICIN
    RAHMAN, A
    GUTIERREZ, P
    RASCHID, S
    MHATRE, RL
    SCHEIN, PS
    [J]. FEDERATION PROCEEDINGS, 1981, 40 (03) : 685 - 685
  • [7] PHARMACOKINETICS OF INHALED LIPOSOME-ENCAPSULATED FENTANYL
    HUNG, OR
    WHYNOT, SC
    VARVEL, JR
    SHAFER, SL
    MEZEI, M
    [J]. ANESTHESIOLOGY, 1995, 83 (02) : 277 - 284
  • [8] PHARMACOKINETICS OF SUB-CONJUNCTIVAL LIPOSOME-ENCAPSULATED GENTAMICIN IN NORMAL RABBIT EYES
    BARZA, M
    BAUM, J
    SZOKA, F
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1984, 25 (04) : 486 - 490
  • [9] PHARMACOKINETICS AND INVIVO ACTIVITY OF LIPOSOME-ENCAPSULATED GENTAMICIN
    SWENSON, CE
    STEWART, KA
    HAMMETT, JL
    FITZSIMMONS, WE
    GINSBERG, RS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 235 - 240
  • [10] INTRAVITREAL LIPOSOME-ENCAPSULATED DRUGS - A PRELIMINARY HUMAN REPORT
    PEYMAN, GA
    CHARLES, HC
    LIU, KR
    KHOOBEHI, B
    NIESMAN, M
    [J]. INTERNATIONAL OPHTHALMOLOGY, 1988, 12 (03) : 175 - 182